SANTA CLARA, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq:LNDC), a leading innovator of diversified health and wellness solutions within the branded natural food and biomaterial markets, will hold a conference call on Wednesday August 1, 2018 at 8 a.m. Pacific time to discuss its results for the fourth quarter and fiscal year-end 2018. Financial results will be reported for the 2018 fiscal fourth quarter and fiscal year ended May 27, 2018 after market close on July 31, 2018.
Landec's President and CEO, Molly A. Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.
Date: Wednesday August 1, 2018
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: (844) 860-6243
U.S. and International Toll Number: (661) 378-9884
Conference ID: 8777468
The webcast will be available for 30 days through August 31, 2018.
A replay of the teleconference will be available for one week until midnight Eastern Time on Wednesday August 8, 2018.
Toll free replay dial in: (855) 859-2056
International replay: (404) 537-3406
Replay passcode: 8777468
About Landec Corporation
Landec Corporation (Nasdaq:LNDC) is a leading innovator of diversified health and wellness solutions within the packaged natural food and biomaterial markets. Apio is a leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Extending its reach into adjacent natural food products, Landec recently acquired O Olive Oil, an organic and natural producer and marketer of olive oils and vinegars under the O® brand. Lifecore Biomedical, Landec’s biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec’s website at www.landec.com.
|At the Company:||Investor Relations:|
|Gregory S. Skinner||John Mills, Partner|
|Vice President Finance and CFO||(646) 277-1254|